title: Subarachnoid Hemorrhage: An Update.
abstract: Subarachnoid hemorrhage (SAH) is a debilitating, although uncommon, type of stroke with high morbidity, mortality, and economic impact. Modern 30-day mortality is as high as 40%, and about 50% of survivors have permanent disability. Care at high-volume centers with dedicated neurointensive care units is recommended. Euvolemia, not hypervolemia, should be targeted, and the aneurysm should be secured early. Neither statin therapy nor magnesium infusions should be initiated for delayed cerebral ischemia. Cerebral vasospasm is just one component of delayed cerebral edema. Hyponatremia is common in subarachnoid hemorrhage and is associated with longer length of stay, but not increased mortality.
authors: Department of Anesthesiology, University of Kentucky College of Medicine, 800 Rose Street, Suite N202, Lexington, KY 40536-0293, USA. Electronic address: jsdori2@uky.edu.
authors: Jeremy S
authors: JS
authors: Dority
authors: Department of Anesthesiology, University of Kentucky College of Medicine, 800 Rose Street, Suite N202, Lexington, KY 40536-0293, USA.
authors: Jeffrey S
authors: JS
authors: Oldham
mesh_terms: D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D003422:Critical Care; D004621:Embolization, Therapeutic; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications; D011654:Pulmonary Edema / Q000628:therapy; D012964:Sodium / Q000378:metabolism; D015607:Stents; D013345:Subarachnoid Hemorrhage / Q000209:etiology / Q000628:therapy*; D054549:Takotsubo Cardiomyopathy / Q000628:therapy
chemical_list: D000933:Antifibrinolytic Agents; D012964:Sodium
keywords: Cerebral salt wasting; Coiling; Delayed cerebral ischemia; Subarachnoid hemorrhage; Vasospasm